C - Chemistry – Metallurgy – 07 – F
Patent
C - Chemistry, Metallurgy
07
F
C07F 9/58 (2006.01) A61K 31/663 (2006.01) A61P 19/00 (2006.01)
Patent
CA 2649489
The present invention is concerned with new risedronate salts and new polymorphic forms thereof, specifically a pharmaceutically acceptable tetra-(alkali metal) salt of risedronic acid and new polymorphic forms thereof, processes of preparing the same, pharmaceutical compositions containing the same, therapeutic uses thereof and methods of treatment employing the same.
La présente invention concerne de nouveaux sels risedronates et de nouvelles formes polymorphes de ceux-ci, notamment un sel pharmaceutiquement acceptable de tétra-(métal alcalin) de l'acide risedronique et de nouvelles formes polymorphes de celui-ci, des procédés permettant de les préparer, des compositions pharmaceutiques les contenant, leurs utilisations thérapeutiques et des procédés de traitement les employant.
Bajic Blazenko
Dinter Gordan
Kwokal Ana
Mestrovic Ernest
Mihaljevic Kreso
Borden Ladner Gervais Llp
Pliva Hrvatska D.o.o.
LandOfFree
Pharmaceutically acceptable salts and polymorphic forms does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutically acceptable salts and polymorphic forms, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutically acceptable salts and polymorphic forms will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1679796